The Increasing Proportion of Early-Stage Pancreatic Cancer between 2004-2013: A SEER Analysis.
Sven Peter OmanJuan E CorralJohn StaufferMassimo RaimondoKabir ModyMichael WallacePublished in: Cancer investigation (2021)
Pancreatic cancer will become the second leading cause of cancer-related death in the United States by 2030. Survival improves when it is identified at an early-stage and resected. Increasing public attention and cross-section imaging may shift detection to earlier stages. We found a small total increase in the proportion of stage-I cancer relative to all stages and a significant increase compared to distant disease in the Surveillance, Epidemiology, and End Results (SEER) database. Despite this, our ability to screen and identify early-stage disease is still lacking. Additional research and population-based interventions are necessary to improve early detection.
Keyphrases
- early stage
- sentinel lymph node
- lymph node
- healthcare
- public health
- papillary thyroid
- physical activity
- mental health
- working memory
- risk factors
- high throughput
- adverse drug
- lymph node metastasis
- young adults
- mass spectrometry
- label free
- electronic health record
- free survival
- loop mediated isothermal amplification
- quantum dots
- rectal cancer
- data analysis